Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Brachytherapy for locally recurrent soft-tissue sarcoma.

Nora Janjan1, Christopher Crane, Marc Delclos

  • 1University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, U.S.A.

American Journal of Clinical Oncology
|February 2, 2002
PubMed
Summary

Brachytherapy offers a theoretical advantage over external beam radiation for treating recurrent soft-tissue sarcomas by delivering higher radiation doses to the surgical bed. This technique provides a crucial radiotherapeutic option when external beam radiation is not feasible.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Access to Care and the Affordable Care Act: Why Do Problems Exist 15 Years Later?

Oncology (Williston Park, N.Y.)·2026
Same author

Patient-specific fine-tuning of a self-distilled transformer model for normal tissue segmentation in abdominal magnetic resonance guided adaptive radiotherapy.

Physics and imaging in radiation oncology·2026
Same author

Sensitivity of metastatic mucinous tailgut cyst adenocarcinoma to gemcitabine and radiation: a case report.

Frontiers in oncology·2026
Same author

A survey of regulatory recommendations for waivers of <i>in vivo</i> bioequivalence studies of generic products for certain dosage forms by participating regulators and organisations of the International Pharmaceutical Regulators Programme. Part 2.

Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques·2025
Same author

The additive value of morphologic grouping in assessing treatment response to ablative radiation therapy in liver metastases.

Abdominal radiology (New York)·2025
Same author

Organ Preservation in Rectal Cancer: Fear of Risks Versus the Risks of Fear.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2025

Area of Science:

  • Oncology
  • Radiation Oncology
  • Surgical Oncology

Background:

  • Radiation therapy is vital for minimizing local recurrence risk from microscopic residual disease post-surgery.
  • Brachytherapy is an established radiation method for soft-tissue sarcomas recurring after surgery, with or without prior radiation.
  • Recurrent soft-tissue sarcomas in previously irradiated areas often preclude further external beam radiation.

Purpose of the Study:

  • To highlight the theoretical advantages of brachytherapy for recurrent soft-tissue sarcomas.
  • To present brachytherapy as a viable radiotherapeutic alternative for local recurrence control.
  • To outline recommendations for brachytherapy use in managing recurrent soft-tissue sarcomas.

Main Methods:

  • Comparison of brachytherapy and external beam radiation based on radiobiologic principles, particularly the inverse-square law.

Related Experiment Videos

  • Discussion of brachytherapy's ability to deliver higher doses to the surgical bed.
  • Review of clinical scenarios where brachytherapy is the preferred or only radiotherapeutic option.

    • Main Results:

    • Brachytherapy provides higher radiation doses to the surgical bed due to its radiobiologic characteristics (inverse-square law).
    • This higher localized dose offers a theoretical advantage in controlling microscopic residual disease compared to external beam radiation.
    • Brachytherapy serves as a critical alternative when re-irradiation with external beam therapy is not possible.

    Conclusions:

    • Brachytherapy is a valuable tool for managing recurrent soft-tissue sarcomas, especially in previously irradiated sites.
    • Recommendations for patient selection, total radiation dose, and dose-rate are essential for optimal outcomes.
    • Standardized grading systems for response and complications are necessary for consistent evaluation.